Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
If you are interested in any of our products, or would like to discuss a custom order, please do not hesitate to contact us
Research Status Disclaimer: BPC-157 research is primarily based on preclinical animal models and in vitro studies
Also Known As KLOW, BPC-157/TB-500/KPV/GHK-Cu Mechanism of Action Multi-pathway synergistic blend: BPC-157 promotes angiogenesis and growth factor modulation
Sorafenib as a ferroptosis-related clinical drug has been approved by the United States Food and Drug Administration for the treatment of ovarian cancer (98)
US$ 25.98
US$ 28.04
US$ 20.52
US$ 21.57
US$ 27.47
US$ 27.81
US$ 20.13
US$ 29.49
US$ 28.39
US$ 20.44
US$ 24.93
US$ 29.00
